Principal Securities’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,881
Closed -$185K 3561
2025
Q3
$185K Sell
1,881
-106
-5% -$10.5K ﹤0.01% 1323
2025
Q2
$181K Sell
1,987
-146
-7% -$14.1K ﹤0.01% 1269
2025
Q1
$225K Hold
2,133
0.01% 1081
2024
Q4
$225K Buy
2,133
+409
+24% +$43.9K 0.01% 1081
2024
Q3
$186K Sell
1,724
-394
-19% -$43K ﹤0.01% 1133
2024
Q2
$230K Sell
2,118
-93
-4% -$11K 0.01% 990
2024
Q1
$292K Buy
2,211
+264
+14% +$33K 0.01% 872
2023
Q4
$237K Buy
+1,947
New +$217K 0.01% 880

Other funds holding ZBH

Principal Securities's ZBH Position: Q4 2025 in Review

Principal Securities sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 1,881 shares — an estimated $185K sold.

Principal Securities first reported a position in ZBH in Q4 2023 and held it in 8 quarters. The position peaked at $292K in Q1 2024. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Principal Securities reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 1,881 Zimmer Biomet shares in Q4 2025, an estimated $185K.
  • Principal Securities first reported a position in Zimmer Biomet in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Zimmer Biomet position peaked at $292K in Q1 2024.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.